C.H. Sattler

Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension

Christophe Guignabert, Carole Phan, Andrei Seferian et al. · Journal of Clinical Investigation · 2016 · 273 citations · Full text

Medicine, Oncology, Pharmacology +15

Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension

Jason Weatherald, Athénaïs Boucly, D. S. Chemla et al. · Circulation · 2017 · 227 citations · Full text

Medicine, Cardiology, Hemodynamic Management +13

Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension

Nicolas Ricard, Ly Tu, Morane Le Hiress et al. · Circulation · 2014 · 203 citations

Medicine, Cardiology, Physiology +14

Initial dual oral combination therapy in pulmonary arterial hypertension

Olivier Sitbon, C.H. Sattler, Laurent Bertoletti et al. · European Respiratory Journal · 2016 · 143 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Pulmonary arterial hypertension in patients treated with interferon

Laurent Savale, C.H. Sattler, Sven Günther et al. · European Respiratory Journal · 2014 · 107 citations

Medicine, Internal Medicine, Pharmacotherapy +9